Labcorp Holdings (LH) Total Non-Current Liabilities (2009 - 2026)
Labcorp Holdings (LH) posted Total Non-Current Liabilities of $9.6 billion for Q1 2026, up 5.95% sequentially from $9.1 billion in Q4 2025, and up 9.85% YoY from $8.8 billion in Q1 2025.
Labcorp Holdings (LH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Labcorp Holdings has reported Total Non-Current Liabilities for 18 years, with the latest figure at $9.6 billion in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 9.85% year-over-year to $9.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 billion (up 9.85% YoY) and the FY2025 annual result came in at $9.1 billion, down 7.01% from the prior year.
- Total Non-Current Liabilities rose to $9.6 billion in Q1 2026 per LH's latest filing, from $9.1 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $9.9 billion in Q3 2024 and troughed at $8.1 billion in Q1 2024.
- A 5-year average of $9.1 billion and a median of $9.1 billion in 2025 frame the typical range for Total Non-Current Liabilities.
- The widest YoY moves for Total Non-Current Liabilities: up 16.26% in 2024, down 14.19% in 2024.
- Over 5 years, Total Non-Current Liabilities stood at $9.6 billion in 2022, then fell by 12.59% to $8.4 billion in 2023, then increased by 16.26% to $9.8 billion in 2024, then declined by 7.01% to $9.1 billion in 2025, then rose by 5.95% to $9.6 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $9.6 billion, $9.1 billion, and $8.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 209.29 Bn | 205.35 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 137.39 Bn | 133.06 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 46.84 Bn | 46.64 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.29 Bn | 37.48 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Natera | 39.28 Bn | 38.18 Bn | 696.04 Mn | 737.18 Mn |
| 6 | Iqvia Holdings | 37.90 Bn | 35.95 Bn | 1.44 Bn | 22.94 Bn |
| 7 | Illumina | 30.65 Bn | 29.49 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.92 Bn | 28.87 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 25.96 Bn | 25.64 Bn | 1.03 Bn | 15.88 Bn |
| 10 | Labcorp Holdings | 25.71 Bn | 24.73 Bn | 1.01 Bn | 9.65 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.65 Bn |
| Dec 31, 2025 | 9.11 Bn |
| Sep 30, 2025 | 8.91 Bn |
| Jun 30, 2025 | 8.93 Bn |
| Mar 31, 2025 | 8.78 Bn |
| Dec 31, 2024 | 9.80 Bn |
| Sep 30, 2024 | 9.90 Bn |
| Jun 30, 2024 | 8.21 Bn |
| Mar 31, 2024 | 8.09 Bn |
| Dec 31, 2023 | 8.43 Bn |
| Sep 30, 2023 | 8.57 Bn |
| Jun 30, 2023 | 8.50 Bn |
| Mar 31, 2023 | 9.43 Bn |
| Dec 31, 2022 | 9.64 Bn |
| Sep 30, 2022 | 9.28 Bn |
| Jun 30, 2022 | 9.50 Bn |
| Mar 31, 2022 | 9.50 Bn |
| Dec 31, 2021 | 9.69 Bn |
| Sep 30, 2021 | 9.83 Bn |
| Jun 30, 2021 | 9.65 Bn |